Project 2: Testing Multi-Level Interventions to Improve HPV Vaccination

项目 2:测试多层次干预措施以改善 HPV 疫苗接种

基本信息

  • 批准号:
    10381631
  • 负责人:
  • 金额:
    $ 24.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-11 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY – PROJECT 2 Prior research has demonstrated that health care provider recommendation is the most influential factor affecting HPV vaccine uptake and completion among adolescents and young adults. However, many providers are not recommending the vaccine at opportunistic times such as the targeted ages of 11-12 when most children receive Tdap and meningococcal vaccines. To improve the uptake of the HPV vaccine among 11-12 year olds – the age group of focus for the Centers for Disease Control and Prevention (CDC) – a multi-disciplinary research team across four Appalachian states will test the effectiveness of a health system-based intervention, as part of an integrated clinic-based cervical cancer prevention program (with Projects 1 and 3), that is directed to three levels of influence – clinic, provider, and patient. Using a delayed intervention design in a group randomized implementation trial, we will examine outcomes of effectiveness, acceptability, and sustainability along the Implementation Science Framework. We will also test in a secondary aim whether interventions targeted to the 13-26 year olds increases catch-up vaccination. This study is part of the Program Project, “Improving Uptake of Cervical Cancer Prevention Services in Appalachia,” and as such, is intricately integrated with the Cores of the Program. The interventions to be tested have been developed in conjunction with community partners, address multi-level factors within the Social Determinants of Health that impact disparities in HPV-related disease, and have been piloted in Appalachian populations. Specific aims are to: 1) Primary Outcome: Test the effectiveness of a multi-level intervention directed at clinics, providers, and patients (parents of children aged 11-12) to improve HPV vaccine initiation and completion in health systems in four Appalachian states (KY, OH, WV, and VA) among children aged 11-12, and assess the effectiveness of the intervention program among subgroups, e.g., females vs males; 2) Secondary Outcomes: Assess: a) sustainability of the intervention; b) cost impacts of the intervention; c) changes in clinic practices that occur as a result of the intervention in terms of staff responsibilities for the vaccination process and reducing missed opportunities for vaccination; and d) whether interventions directed to 13-26 year olds increases catch-up vaccination; and 3) Secondary Outcomes: Examine: a) changes in knowledge and attitudes of providers via educational session pre-post surveys and b) satisfaction with the intervention at the multiple levels. If effective, this multi-level intervention will be disseminated to our clinical and community partners as well as other partners throughout Appalachia to facilitate the uptake of effective interventions throughout health systems and clinics in Appalachia to help reduce the burden of HPV-preventable diseases.
项目总结-项目2

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELECTRA D. PASKETT其他文献

ELECTRA D. PASKETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELECTRA D. PASKETT', 18)}}的其他基金

Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10381633
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10495879
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10268467
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Project 2: Testing Multi-Level Interventions to Improve HPV Vaccination
项目 2:测试多层次干预措施以改善 HPV 疫苗接种
  • 批准号:
    10627804
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10268468
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10381634
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10701200
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10268456
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10627826
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10268455
  • 财政年份:
    2019
  • 资助金额:
    $ 24.33万
  • 项目类别:

相似海外基金

NORMAL VALUES FOR BONE MINERAL DENSITY IN 15-21 YEAR OLD WHITE FEMALE
15-21 岁白人女性骨矿物质密度的正常值
  • 批准号:
    3885726
  • 财政年份:
  • 资助金额:
    $ 24.33万
  • 项目类别:
NORMAL VALUES FOR BONE MINERAL DENSITY IN 15-21 YEAR OLD WHITE FEMALES
15-21 岁白人女性骨矿物质密度的正常值
  • 批准号:
    3864747
  • 财政年份:
  • 资助金额:
    $ 24.33万
  • 项目类别:
BONE DENSITY NORMAL VALUES 15 21 YEAR OLD FEMALES
骨密度正常值 15 21 岁女性
  • 批准号:
    3868926
  • 财政年份:
  • 资助金额:
    $ 24.33万
  • 项目类别:
BONE DENSITY: NORMAL VALUES: 15-21 YEAR OLD FEMALES
骨密度:正常值:15-21 岁女性
  • 批准号:
    3890270
  • 财政年份:
  • 资助金额:
    $ 24.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了